Literature DB >> 17360322

Human herpesvirus 6A accelerates AIDS progression in macaques.

Paolo Lusso1, Richard W Crowley, Mauro S Malnati, Clelia Di Serio, Maurilio Ponzoni, Angelique Biancotto, Phillip D Markham, Robert C Gallo.   

Abstract

Although HIV is the necessary and sufficient causative agent of AIDS, genetic and environmental factors markedly influence the pace of disease progression. Clinical and experimental evidence suggests that human herpesvirus 6A (HHV-6A), a cytopathic T-lymphotropic DNA virus, fosters the progression to AIDS in synergy with HIV-1. In this study, we investigated the effect of coinfection with HHV-6A on the progression of simian immunodeficiency virus (SIV) disease in pig-tailed macaques (Macaca nemestrina). Inoculation of HHV-6A resulted in a rapid appearance of plasma viremia associated with transient clinical manifestations and followed by antibody seroconversion, indicating that this primate species is susceptible to HHV-6A infection. Whereas animals infected with HHV-6A alone did not show any long-term clinical and immunological sequelae, a progressive loss of CD4(+) T cells was observed in all of the macaques inoculated with SIV. However, progression to full-blown AIDS was dramatically accelerated by coinfection with HHV-6A. Rapid disease development in dually infected animals was heralded by an early depletion of both CD4(+) and CD8(+) T cells. These results provide in vivo evidence that HHV-6A may act as a promoting factor in AIDS progression.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17360322      PMCID: PMC1829265          DOI: 10.1073/pnas.0700929104

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  40 in total

1.  Prospective study of human herpesvirus 6, human herpesvirus 7, and cytomegalovirus infections in human immunodeficiency virus-positive patients.

Authors:  G Fabio; S N Knight; I M Kidd; S M Noibi; M A Johnson; V C Emery; P D Griffiths; D A Clark
Journal:  J Clin Microbiol       Date:  1997-10       Impact factor: 5.948

2.  Expression of macrophage inflammatory protein (MIP)-1alpha, MIP-1beta, and RANTES genes in lymph nodes from HIV+ individuals: correlation with a Th1-type cytokine response.

Authors:  C Trumpfheller; K Tenner-Racz; P Racz; B Fleischer; S Frosch
Journal:  Clin Exp Immunol       Date:  1998-04       Impact factor: 4.330

3.  Primary infection of human herpesvirus 6 in children with vertical infection of human immunodeficiency virus type 1.

Authors:  U Kositanont; C Wasi; N Wanprapar; P Bowonkiratikachorn; K Chokephaibulkit; S Chearskul; K Chimabutra; R Sutthent; S Foongladda; R Inagi; T Kurata; K Yamanishi
Journal:  J Infect Dis       Date:  1999-07       Impact factor: 5.226

4.  Cyclosporin A modulation of early virologic and immunologic events during primary simian immunodeficiency virus infection in rhesus monkeys.

Authors:  L N Martin; M Murphey-Corb; P Mack; G B Baskin; G Pantaleo; M Vaccarezza; C H Fox; A S Fauci
Journal:  J Infect Dis       Date:  1997-08       Impact factor: 5.226

5.  Quantitative evaluation of simian immunodeficiency virus infection using NASBA technology.

Authors:  J W Romano; R N Shurtliff; E Dobratz; A Gibson; K Hickman; P D Markham; R Pal
Journal:  J Virol Methods       Date:  2000-04       Impact factor: 2.014

6.  In vivo evolution of HIV-1 co-receptor usage and sensitivity to chemokine-mediated suppression.

Authors:  G Scarlatti; E Tresoldi; A Björndal; R Fredriksson; C Colognesi; H K Deng; M S Malnati; A Plebani; A G Siccardi; D R Littman; E M Fenyö; P Lusso
Journal:  Nat Med       Date:  1997-11       Impact factor: 53.440

7.  Interactions between beta-herpesviruses and human immunodeficiency virus in vivo: evidence for increased human immunodeficiency viral load in the presence of human herpesvirus 6.

Authors:  V C Emery; M C Atkins; E F Bowen; D A Clark; M A Johnson; I M Kidd; J E McLaughlin; A N Phillips; P M Strappe; P D Griffiths
Journal:  J Med Virol       Date:  1999-03       Impact factor: 2.327

8.  Mycobacterium bovis bacille Calmette-Guérin enhances pathogenicity of simian immunodeficiency virus infection and accelerates progression to AIDS in macaques: a role of persistent T cell activation in AIDS pathogenesis.

Authors:  D Zhou; Y Shen; L Chalifoux; D Lee-Parritz; M Simon; P K Sehgal; L Zheng; M Halloran; Z W Chen
Journal:  J Immunol       Date:  1999-02-15       Impact factor: 5.422

9.  Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells.

Authors:  F Cocchi; A L DeVico; A Garzino-Demo; S K Arya; R C Gallo; P Lusso
Journal:  Science       Date:  1995-12-15       Impact factor: 47.728

10.  Active HHV-6 infection in the lymph nodes of HIV-infected patients: in vitro evidence that HHV-6 can break HIV latency.

Authors:  K K Knox; D R Carrigan
Journal:  J Acquir Immune Defic Syndr Hum Retrovirol       Date:  1996-04-01
View more
  25 in total

1.  The latent human herpesvirus-6A genome specifically integrates in telomeres of human chromosomes in vivo and in vitro.

Authors:  Jesse H Arbuckle; Maria M Medveczky; Janos Luka; Stephen H Hadley; Andrea Luegmayr; Dharam Ablashi; Troy C Lund; Jakub Tolar; Kenny De Meirleir; Jose G Montoya; Anthony L Komaroff; Peter F Ambros; Peter G Medveczky
Journal:  Proc Natl Acad Sci U S A       Date:  2010-03-08       Impact factor: 11.205

2.  Human herpesvirus 6A infection and immunopathogenesis in humanized Rag2⁻/⁻ γc⁻/⁻ mice.

Authors:  Anne Tanner; Stephanie A Carlson; Masatoshi Nukui; Eain A Murphy; Bradford K Berges
Journal:  J Virol       Date:  2013-09-04       Impact factor: 5.103

Review 3.  The molecular biology of human herpesvirus-6 latency and telomere integration.

Authors:  Jesse H Arbuckle; Peter G Medveczky
Journal:  Microbes Infect       Date:  2011-03-31       Impact factor: 2.700

Review 4.  Recent developments in animal models for human herpesvirus 6A and 6B.

Authors:  Branka Horvat; Bradford K Berges; Paolo Lusso
Journal:  Curr Opin Virol       Date:  2014-10-14       Impact factor: 7.090

5.  Discovery and biological characterization of two novel pig-tailed macaque homologs of HHV-6 and HHV-7.

Authors:  Jeannette P Staheli; Michael R Dyen; Patrick Lewis; Serge Barcy
Journal:  Virology       Date:  2014-10-31       Impact factor: 3.616

6.  Interactions between viral and prokaryotic pathogens in a mixed infection with cardiovirus and mycoplasma.

Authors:  Peter V Lidsky; Lyudmila I Romanova; Marina S Kolesnikova; Maryana V Bardina; Elena V Khitrina; Stanleyson V Hato; Frank J M van Kuppeveld; Vadim I Agol
Journal:  J Virol       Date:  2009-07-15       Impact factor: 5.103

7.  Human herpesvirus 6A infection in CD46 transgenic mice: viral persistence in the brain and increased production of proinflammatory chemokines via Toll-like receptor 9.

Authors:  Joséphine M Reynaud; Jean-François Jégou; Jérémy C Welsch; Branka Horvat
Journal:  J Virol       Date:  2014-02-26       Impact factor: 5.103

Review 8.  Classification of HHV-6A and HHV-6B as distinct viruses.

Authors:  Dharam Ablashi; Henri Agut; Roberto Alvarez-Lafuente; Duncan A Clark; Stephen Dewhurst; Dario DiLuca; Louis Flamand; Niza Frenkel; Robert Gallo; Ursula A Gompels; Per Höllsberg; Steven Jacobson; Mario Luppi; Paolo Lusso; Mauro Malnati; Peter Medveczky; Yasuko Mori; Philip E Pellett; Joshua C Pritchett; Koichi Yamanishi; Tetsushi Yoshikawa
Journal:  Arch Virol       Date:  2013-11-06       Impact factor: 2.574

9.  Downregulation of the T-cell receptor complex and impairment of T-cell activation by human herpesvirus 6 u24 protein.

Authors:  Brian M Sullivan; Laurent Coscoy
Journal:  J Virol       Date:  2007-10-31       Impact factor: 5.103

10.  Mapping the telomere integrated genome of human herpesvirus 6A and 6B.

Authors:  Jesse H Arbuckle; Shara N Pantry; Maria M Medveczky; Joshua Prichett; Kristin S Loomis; Dharam Ablashi; Peter G Medveczky
Journal:  Virology       Date:  2013-05-04       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.